Can BPC-157 cause diarrhea?

This site's BPC-157 citations do not report diarrhea as a counted adverse event. The human record is five small studies, fewer than 110 people, including a 53-patient ulcerative colitis randomized trial that measured disease activity, not a diarrhea table from the peptide. FDA's three adverse-event reports name injection-site reactions, shortness of breath, and hyperpigmentation, not diarrhea. Absence of a counted rate is not proof that nobody's gut is affected. It is proof that this FAQ cannot publish one. This FAQ does not invent an adverse-event rate the citations do not contain.

Educational use only. This database summarizes published research and is not medical advice. Where a dose appears it is a record of what a trial or clinic ran, or what people describe doing, with its source attached. Nothing here is a recommendation for personal use.

Part of healing and recovery peptides. BPC-157, TB-500, GHK-Cu, and the tissue repair family, including what actually has human data.